Talha Munir Selected Research

Talha Munir Research Topics

18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 01/2018
5	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 02/2024 - 01/2018
5	Infections 12/2023 - 01/2020
5	Residual Neoplasm 01/2023 - 01/2017
4	Hemolysis 02/2024 - 01/2020
4	Disease Progression 12/2023 - 06/2016
4	Hypertension (High Blood Pressure) 07/2023 - 12/2019
4	COVID-19 01/2022 - 01/2020
3	Hemorrhage 07/2023 - 01/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2023 - 01/2018
3	Neoplasms (Cancer) 07/2023 - 08/2021
3	Atrial Fibrillation 07/2023 - 12/2019
3	Thrombosis (Thrombus) 01/2022 - 03/2017
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 01/2018
2	Neutropenia 07/2023 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2020
1	Heart Failure 12/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023
1	Sick Sinus Syndrome 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	Lymphocytosis 07/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2023
1	Lupus Nephritis 07/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 07/2023
1	Hemoglobinuria 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Headache (Headaches) 01/2023
1	Dyspepsia (Indigestion) 01/2023
1	Diarrhea 01/2023
1	Leukopenia 01/2023
1	Cough 01/2023
1	Back Pain (Backache) 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Spasm (Spasms) 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Arthralgia (Joint Pain) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Large Granular Lymphocytic Leukemia 12/2016

12	ibrutinibIBA 12/2023 - 01/2017
10	venetoclaxIBA 12/2023 - 06/2016
8	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 12/2019
6	eculizumab FDA Link 02/2024 - 03/2017
5	obinutuzumabIBA 12/2023 - 01/2020
5	acalabrutinibIBA 06/2023 - 01/2020
4	Chlorambucil (Leukeran)FDA Link 12/2023 - 01/2020
3	Complement System Proteins (Complement)IBA 12/2023 - 01/2020
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2020
2	pegcetacoplanIBA 02/2024 - 01/2023
2	Monoclonal AntibodiesIBA 12/2023 - 12/2022
2	pirtobrutinibIBA 07/2023 - 01/2023
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2017
2	fludarabineIBA 01/2023 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2022
2	eltrombopag FDA Link 01/2022 - 11/2019
1	ravulizumabIBA 12/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2023
1	Antinuclear AntibodiesIBA 07/2023
1	SS-A antibodiesIBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	ceralasertibIBA 01/2023
1	AlbuminsIBA 01/2022
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	GPI-Linked ProteinsIBA 08/2021
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 08/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	FibrinIBA 01/2020
1	Vitamin K FDA Link 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016

15	Therapeutics 05/2024 - 01/2017
1	Duration of Therapy 07/2023
1	Immunotherapy 12/2022
1	Critical Care (Surgical Intensive Care) 01/2020